Creating Best in Class Human iPSC-Derived Cell Models to Address the Spectrum of ALS From Target Discovery to Translation
Time: 11:15 am
day: Day Two Track A AM
Details:
- Highlighting characterization and functional data on precision programmed ioMotor Neurons including gene expression, morphology and MEA
- Introducing bit.bio’s ioDisease Models to develop phenotypic screening and functional assays in our ioGlutamatergic and ioMotor Neurons to address the challenges of CNS drug discovery
- Exploring future pathways in ALS including co-culture models, CRISPR-mediated target discovery and the neuroinflammatory components of ALS
